MNHS researchers awarded over $46 million in NHMRC Investigator Grants
Research projects to improve treatments in critical care medicine, drug-resistant epilepsy and sexually transmitted infections are among 26 projects awarded to Monash Medicine Nursing and Health Sciences researchers in the latest National Health and Medical Research Council (NHMRC) Investigator Grants funding, announced yesterday by Federal Minister for Health and Ageing The Hon Mark Butler MP.
The grants were among $411 million awarded to 229 researchers to investigate Australia’s greatest health challenges. The Investigator Grant scheme is the NHMRC’s largest funding scheme and is a major investment in Australia’s health and medical research workforce. It provides Australia’s highest-performing researchers, across the spectrum of health research and at all career stages, with consolidated funding for their salary, if required, and a significant research support package for five years.
This year’s grants also included gender equity targets to address systemic disadvantage faced by female and non-binary applicants. For the second time in the history of the scheme, women researchers will receive more funding overall, including at the most senior levels of the scheme.
Professor Mike Ryan, Interim Deputy Vice-Chancellor (Research), said the grants were a recognition of the strength of health and medical research at Monash."These grants recognise the outstanding work of Monash University researchers in creating significant health outcomes and improvements for the community. It’s also fantastic to see the initiatives introduced by the NHMRC to address gender inequities have led to an equal number of women receiving Investigator Grants this year. Congratulations to all recipients.”
Professor James Whisstock, Deputy Dean Research, congratulated the recipients. “We’re delighted and proud that our researchers have been successful in receiving prestigious Investigator Grant funding,” he said. “Health and medical research is fundamental to achieving high-quality and equitable clinical care outcomes in our hospitals and the wider community. This investment in our researchers will allow them to continue striving to solve the country’s most pressing health challenges,” he said.
Funding recipients include:
Category | Researcher | School/Institute | Project | Amount |
Leadership 3 | School of Public Health and Preventive Medicine | Research programs and pivotal trials to improve outcomes in critical care medicine | $2,981,630 | |
Leadership 3 | School of Translational Medicine | Applying innovative approaches to developing transformational treatments for people with drug-resistant epilepsy | $2,981,630 | |
Leadership 2 | Monash Biomedicine Discovery Institute | Harnessing disease tolerance and immune protection to treat fungal sepsis | $2,524,080 | |
Leadership 2 | School of Public Health and Preventive Medicine | Improving the quality of survival after critical illness | $2,924,080 | |
Leadership 2 | Hudson Institute of Medical Research, School of Clinical Sciences at Monash Health | Developing and Repurposing Therapies: Pioneering Interventional Immunology for Early Life Diseases & Beyond | $2,924,080 | |
Leadership 2 | Melbourne Sexual Health Centre, School of Translational Medicine | Transforming the management of treatment-refractory sexually transmitted infections (STI) and STI syndromes with precision medicine and genomics | $2,924,080 | |
Leadership 1 | School of Translational Medicine | Towards Elimination of Avoidable Infections in Surgery | $2,792,745 | |
Leadership 1 | Melbourne Sexual Health Centre, School of Translational Medicine | Optimising the use of antibiotics for sexually transmitted infections to improve antimicrobial stewardship | $2,792,745 | |
Leadership 1 | Monash Biomedicine Discovery Institute | A molecular approach to unlocking B cell memory potential | $2,792,745 | |
Leadership 1 | School of Public Health and Preventive Medicine | Developing, translating and implementing biostatistical expertise in stepped wedge cluster randomised trials | $2,792,745 | |
Leadership 1 | School of Clinical Sciences at Monash Health | Personalising brain care in preterm babies | $2,396,372.50 | |
Emerging Leadership 2 | School of Public Health and Preventive Medicine | Novel approaches to enhance the quality of systematic reviews that underpin public health and policy decisions | $1,503,775 | |
Emerging Leadership 2 | Turner Institute for Brain and Mental Health, School of Psychological Sciences | Healthy sleep: Advancing the treatment and prevention of insomnia | $1,403,775 | |
Emerging Leadership 2 | School of Translational Medicine | Androgen disruption as a novel treatment approach in hormone 'insensitive' cancers | $1,603,775 | |
Emerging Leadership 2 | School of Clinical Sciences at Monash Health | Improving health outcomes for sick and premature infants | $1,362,265 | |
Emerging Leadership 2 | School of Public Health and Preventive Medicine | Advancing the evidence base in cardiac arrest and resuscitation | $1,483,020 | |
Emerging Leadership 2 | Monash Centre for Health Research and Implementation (MCHRI) | Improving understanding of natural history, refining diagnosis and optimising health outcomes in women with polycystic ovary syndrome – a prevalent, yet underserved population | $1,362,265 | |
Emerging Leadership 2 | School of Public Health and Preventive Medicine | Data-driven approaches to outsmart skin cancer | $1,362,265 | |
Emerging Leadership 2 | School of Public Health and Preventive Medicine | Optimising the scale-up of evidence-based tools for control and local elimination of dengue | $1,603,775 | |
Emerging Leadership 1 | Monash Biomedicine Discovery Institute | How does RNA regulate gene repression? | $674,400 | |
Emerging Leadership 1 | Monash Biomedicine Discovery Institute | Cell death at the host-pathogen interface | $674,400 | |
Emerging Leadership 1 | Turner Institute for Brain and Mental Health, School of Psychological Sciences | Understanding the structure and genetic and neurobiological mechanisms of adult psychopathology | $674,400 | |
Emerging Leadership 1 | Turner Institute for Brain and Mental Health, School of Psychological Sciences | Next-generation techniques for mapping and modelling brain changes in clinical disorders | $674,400 | |
Emerging Leadership 1 | School of Translational Medicine | Innovating diagnostics, antibiotic treatment, and prevention strategies for urinary tract infections | $674,400 | |
Emerging Leadership 1 | Dr Lee Fletcher | Spatiotemporal patterning of dendritic computations and learning by cholinergic inputs in the neocortex | $674,400 | |
Emerging Leadership 1 | School of Translational Medicine | Advancing diagnosis, management & prevention of antimicrobial-resistant bacterial infections with genomics | $674,400 |
For a full list of recipients, please visit the National Health and Medical Research Council
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.
For more news, visit Medicine, Nursing and Health Sciences or Monash University.
MEDIA ENQUIRIES